Abivax (ABVX) Non Operating Income (2024 - 2026)
Abivax (ABVX) recorded quarterly Non Operating Income of $9.4 million in Q1 2026, up 280.04% quarter-over-quarter from -$5.2 million in Q4 2025, and up 271.99% on a YoY basis from $2.5 million in Q1 2025.
Abivax (ABVX) Non Operating Income (2024 - 2026) Analysis & Trends
Abivax's Non Operating Income history runs 3 years deep, the most recent figure standing at $9.4 million for Q1 2026.
- In Q1 2026, Non Operating Income rose 271.99% year-over-year to $9.4 million; the TTM figure through Mar 2026 stood at -$82.9 million (down 652.43% YoY), while the FY2025 annual figure was -$98.0 million, down 2715.18% from the prior year.
- Non Operating Income was $9.4 million for Q1 2026 at Abivax, up from -$5.2 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $9.4 million in Q1 2026 to a low of -$84.9 million in Q3 2025.
- Historically, Non Operating Income has averaged -$10.2 million across 3 years, with a median of -$3.7 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Non Operating Income plunged 1435.29% in 2025, then surged 271.99% in 2026.
- A 3-year view of Non Operating Income shows it stood at $3.7 million in 2024, then slumped by 242.11% to -$5.2 million in 2025, then surged by 280.04% to $9.4 million in 2026.
- The last three Non Operating Income figures came in at $9.4 million (Q1 2026), -$5.2 million (Q4 2025), and -$84.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 9.35 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 201.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.35 Mn |
| Dec 31, 2025 | -5.20 Mn |
| Sep 30, 2025 | -84.93 Mn |
| Jun 30, 2025 | -2.17 Mn |
| Mar 31, 2025 | -5.44 Mn |
| Dec 31, 2024 | 3.66 Mn |
| Sep 30, 2024 | -5.53 Mn |
| Jun 30, 2024 | -3.71 Mn |
| Mar 31, 2024 | 1.96 Mn |